@misc{indiciae5479cb230524,
  title = {Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell},
  author = {Hu, Y. and Jo, H. and DeGrado, W. and Wang, J.},
  year = {2021},
  doi = {10.1101/2021.11.04.467344},
  url = {https://www.biorxiv.org/content/10.1101/2021.11.04.467344v1},
  note = {Source identifier: 10.1101/2021.11.04.467344}
}